Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE) (EMINENCE)

This study has been completed.
Information provided by (Responsible Party):
Momenta Pharmaceuticals, Inc. Identifier:
First received: October 11, 2007
Last updated: April 30, 2013
Last verified: April 2013